IMRA
$16.03
Imara
$.09
.56%
IMRA
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.83)
Revenue:  $0.00 Mil
Friday
Nov 13
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when IMRA reports earnings?
Beat
Meet
Miss

Where is IMRA's stock price going from here?
Up
Flat
Down
Stock chart of IMRA
Analysts
Summary of analysts' recommendations for IMRA
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Imara Inc. is a biopharmaceutical company. It engages in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of haemoglobin. The company's product pipeline consists of IMR-687, which are in clinical stage. Imara Inc. is based in Boston, Massachusetts.